Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population (NCT02655432) | Clinical Trial Compass
WithdrawnNot Applicable
Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population
Stopped: waiting for ethic board approval
Haiti0Started 2016-01
Plain-language summary
Screening of haitian children between the ages of 3 and 6 years old for amblyogenic risk factors with the use of the Spot photoscreener. The photoscreener results will be compared to the complete ophthalmologic evaluation. Primarily, this will allow evaluation of the performance of the spot photoscreener in the haitian children population. Secondarily, this study will gather epidemiological information on vision problems in the haitian children population.
Who can participate
Age range
3 Years – 6 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Haitian children aged 3-6 years of age
* Signed consent form from a legal guardian
Exclusion Criteria:
* Previous vision problem diagnostic
* Unsigned consent form
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Since this trial was withdrawn before enrolling any participants, can you tell me what other active studies or screening programs in Haiti or similar settings might be looking at vision problems like amblyopia, cataracts, or retinoblastoma in children?
2This study was focused on using a photoscreener to detect a wide range of eye conditions in Haitian children — is photoscreening something that's already available or recommended as part of my child's routine eye care, even outside of a research setting?
3Given that this trial never ran, what do we currently know about how common conditions like retinoblastoma or retinopathy of prematurity are in pediatric populations similar to my child's, and how does that affect how urgently we should be screening?
4Since the trial covered so many different eye conditions — from glaucoma to trachoma to myopia — which of these should we be most focused on evaluating for my child right now based on their specific symptoms or risk factors?
5Are there any other research programs or nonprofit vision screening initiatives working with pediatric populations, especially in under-resourced settings, that might give my child access to thorough eye screening that this withdrawn trial was originally designed to provide?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of patients presenting significant ophthalmologic pathologies in an haitian pediatric population